Amgen (AMGN) Tops Q3 EPS by 24c, FY Guidance Tops Views

Amgen (NASDAQ: AMGN) reported Q3 EPS of $3.69, $0.24 better than the analyst estimate of $3.45. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $5.77 billion.

GUIDANCE:

Amgen sees FY2018 EPS of $14.00-$14.25, versus the consensus of $14.02. Amgen sees FY2018 revenue of $23.2-23.5 billion, versus the consensus of $23.17 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Canaccord Reiterates Hold Rating on Yeti Holdings Inc. (YETI)
• William Blair Starts Yesway Inc (YSWY) at Outperform